Amyndas Pharmaceuticals
Manufacturing · Wyoming, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
125 S King St Ste 2A, Jackson, Wyoming, ...Website
www.amyndas.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Amyndas Pharmaceuticals
Amyndas Pharmaceuticals is a pharmaceutical company focused on developing potent complement therapeutics aimed at treating inflammatory diseases and disorders. The company utilizes its patented technology to modulate the complement system, which plays a crucial role in these conditions. Their research and development efforts are centered on advancing the next generation of complement therapeutics. Amyndas targets healthcare providers and patients affected by inflammatory diseases.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Amyndas Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Amyndas Pharmaceuticals
Funding: Get notified immidiatlly once Amyndas Pharmaceuticals has new funding data
Earning: See what the market has to say on Amyndas Pharmaceuticals recently announced quarterly report
Check if Amyndas Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Amyndas Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Amyndas Pharmaceuticals is spiking on competitors!
Product Launch: Get notified when Amyndas Pharmaceuticals launches new products
Click to see if Amyndas Pharmaceuticals had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Amyndas Pharmaceuticals
Find 3 more new buyers
Compare Similar Companies to Amyndas Pharmaceuticals
Compare insights from companies similar to Amyndas Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Amyndas Pharmaceuticals
<$5M
1-10
Private
-
-
N/A
Company Profile Activity
Activity Insights
Amyndas Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Amyndas Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Amyndas Pharmaceuticals.
Amyndas Pharmaceuticals Tech Stack
A closer look at the technologies used by Amyndas Pharmaceuticals
See more technologies
Amyndas Pharmaceuticals News & Media
Quartesian Announces Amyndas Partnership for COVID-19 Clinical Trial
Quartesian, a multinational Clinical Research Organization (CRO) serving the biopharmaceutical and medical device industries, today announced a new partnership with Amyndas Pharmaceuticals for their Phase 2 clinical study evaluating the efficacy of AMY-101 in COVID-19 patients with acute respiratory distress syndrome (ARDS). ARDS, a life-threatening type of lung failure, is a common complication in severe COVID-19 patients.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Amyndas Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Amyndas Pharmaceuticals is a pharmaceutical company focused on developing potent complement therapeutics aimed at treating inflammatory diseases and disorders. The company utilizes its patented technology to modulate the complement system, which plays a crucial role in these conditions. Their research and development efforts are centered on advanci... Read More
